Therefore, STK35 overexpression was capable of completely offsetting the observed anti-CRC effects exhibited by NEDD4L overexpression, and it simultaneously recued the cellular p-AKT back to an even higher level. The gene discussed is AKT1; the disease is colorectal carcinoma.